MBIO – mustang bio, inc. (US:NASDAQ)
Stock Stats
News
Blastic Plasmacytoid Dendritic Cell Neoplasm Market Research and Forecast Report 2025-2035: CD123-Targeted Therapies Emerge as the Leading Opportunity, Driven by ADCs, CAR-T, Bispecific Development [Yahoo! Finance]
Mustang Bio (NASDAQ:MBIO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Mustang Bio (NASDAQ:MBIO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form DEF 14A MUSTANG BIO, INC. For: Dec 22
Form 10-Q MUSTANG BIO, INC. For: Sep 30
Form SCHEDULE 13D/A MUSTANG BIO, INC. Filed by: Fortress Biotech, Inc.
Form 4 MUSTANG BIO, INC. For: Sep 29 Filed by: Fortress Biotech, Inc.
Form 424B5 MUSTANG BIO, INC.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.